MedTech Dive

The testing service providers hope the legislation, which would reform the CMS’ reimbursement rate-setting process, can cross the finish line in Congress’ lame-duck session.

CEO Kevin Lobo said the slowdown in hip and knee procedures is tied to broader economic concerns. The outgoing CEO also detailed the company’s decision to partner with CMR Surgical.

The company notified customers this month that it will discontinue Medline brand beds and associated products and exit the market.

Weeks after an investor called for leadership changes, Cooper has parted ways with its CEO and proposed a new-look board of directors.

M&A rose, but company valuations declined in the first half of 2026 compared with the year-ago period, according to EY’s Pulse of the Industry report.

The first-of-its-kind transcatheter device treats paravalvular leak after valve replacement surgery, to spare the patient from another open-heart surgery.

The medical device company’s stock dropped when the market opened Wednesday after it slashed sales and earnings forecasts once again.

The acquisition, which will give RadNet a new professional services unit, is expected to help hospitals solve challenges with radiology coverage.

The deal expands Stryker’s portfolio of fast-growing sports medicine and shoulder care devices.

Dr. Rick Baehner, Abbott’s chief medical officer for precision oncology, spoke to MedTech Dive about how the new version of the Oncodetect test performs and the market it addresses.

Medtech CEOs and consultants advised focusing on a core market and preparing for complex processes in a highly regulated industry.

At AdvaMed’s The MedTech Conference, CEOs from top medical device companies shared how they navigate difficult times, inflation and new technologies.

The proposed acquisition of the specialty laboratory is the third Labcorp buyout announced in eight days.

For medical device manufacturers, reshoring has been discussed for years. Now, many are putting it into action and hitting familiar capacity challenges along the way.

Provider groups are lobbying the Food and Drug Administration to make tech companies responsible for the safety and performance of generative AI-backed medical devices, arguing the tools’ makers are best equipped to evaluate them.

More than 4,000 people across the medtech sector met in Boston for one of the industry’s biggest events of the year. Catch up on all the conference news in MedTech Dive’s roundup.

EQT Private Equity has agreed to pay about $12.1 billion, including debt, for the diagnostics company, which has long been the subject of takeover speculation.

Edwards’ approval should “strengthen the company’s position in the large and underpenetrated transcatheter tricuspid market,” analysts said.

The testing company believes an unauthorized third party accessed patient records.

The FDA import alert broadens the scope of a 2025 import action covering dozens of endoscopes and comes two weeks after a new warning letter identified numerous quality system violations.